Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Arrhythmia Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 36 | 44 |
|
Arrhythmogenic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 26 | 18 |
|
Cardiomyopathy and Arrhythmia Panel Mayo Clinic Laboratories Mayo Clinic United States | 73 | 105 |
|
Comprehensive Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 68 | 83 |
|
Hypertrophic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 44 | 48 |
|
Dilated Cardiomyopathy/LVNC Panel Mayo Clinic Laboratories Mayo Clinic United States | 52 | 63 |
|
Brugada Syndrome, SCN5A Full Gene Mayo Clinic Laboratories Mayo Clinic United States | 12 | 1 |
|
Health in Code Spain | 1 | 39 |
|
Health in Code Spain | 1 | 81 |
|
Standard dilated cardiomyopathy Stage 1 Health in Code Spain | 1 | 1 |
|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 100 | 61 |
|
Dilated cardiomyopathy associated with skeletal myopathy and/or elevated CPK level Stage 2 Health in Code Spain | 1 | 1 |
|
Dilated cardiomyopathy associated with skeletal myopathy and/or elevated CPK level Stage 1 Health in Code Spain | 1 | 1 |
|
Dilated cardiomyopathy associated with hypertrabeculation Stage 3 Health in Code Spain | 1 | 2 |
|
Dilated cardiomyopathy associated with hypertrabeculation Stage 2 Health in Code Spain | 1 | 1 |
|
Dilated cardiomyopathy associated with hypertrabeculation Stage 1 Health in Code Spain | 1 | 5 |
|
Dilated cardiomyopathy with alteration of the right ventricle Health in Code Spain | 1 | 4 |
|
Dilated cardiomyopathy with frequent ventricular arrhythmias Stage 2 Health in Code Spain | 1 | 4 |
|
Dilated cardiomyopathy with frequent ventricular arrhythmias Stage 1 Health in Code Spain | 1 | 1 |
|
Dilated cardiomyopathy with restrictive phenotype Stage 2 Health in Code Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.